# Reduction of AF Ablation Induced Thrombo-Embolic Incidence Pilot Study

Study · id `cardio:ct-nct02275260` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02275260](<https://clinicaltrials.gov/study/NCT02275260>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02275260

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 110 participants.

## Technical summary

Registry record NCT02275260. Allocation not applicable; no masking; primary purpose screening. Start 2014-12 (actual); primary completion 2017-02-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose screening
- Phase: Not applicable
- Enrolled: 110 participants (enrolled count; ClinicalTrials.gov record NCT02275260, source copy `cardio:ctgov-nct02275260-2019-11-01`, retrieved 2026-10-26)
- Started: 2014-12 (actual) (ClinicalTrials.gov record NCT02275260, source copy `cardio:ctgov-nct02275260-2019-11-01`, retrieved 2026-10-26)
- Primary completion: 2017-02-08 (actual) (ClinicalTrials.gov record NCT02275260, source copy `cardio:ctgov-nct02275260-2019-11-01`, retrieved 2026-10-26)
- Completion: 2018-02-15 (actual) (ClinicalTrials.gov record NCT02275260, source copy `cardio:ctgov-nct02275260-2019-11-01`, retrieved 2026-10-26)
- Countries: Czechia; Germany; Hungary; Netherlands; Switzerland (ClinicalTrials.gov record NCT02275260, source copy `cardio:ctgov-nct02275260-2019-11-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02275260-2019-11-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Reduction of AF Ablation Induced Thrombo-Embolic Incidence Pilot Study
- Condition: Paroxysmal Atrial Fibrillation
- Intervention (Device): Cerebral Diffusion-Weighted Magnetic Resonance Imaging
- Intervention (Device): Transesophageal Echocardiography
- Intervention (Other): Paperbased neurocognitive testing
- Lead sponsor: Biotronik SE & Co. KG
- Lead sponsor class: INDUSTRY
- Collaborator: University Hospital Heidelberg
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Biotronik SE & Co. KG (`cardio:org-biotronik-se-co-kg`)
- Registry lists this organization as a collaborator: University Hospital Heidelberg (`cardio:org-university-hospital-heidelberg`)

## Provenance

Content hash: 864c03a3316ee5c650b0104b82a3a8fc949a501f4ae8b4741587637d75c2e61d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
